OP 7.2 – 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: four cases from the open label arm of the RIO trial

• M. Lee,
• S. Collins,
• S. Kinloch,
• J. Fox,
• K. Seaton,
• G. Tomaras,
• M. Caskey,
• M. Nussenzweig,
• J. Frater,
• S. Fidle

Affiliations

M. Lee

Imperial College London, London, United Kingdom

S. Collins

HIV Ibase, London, United Kingdom

S. Kinloch

Royal Free Hospital NHS Foundation Trust, London, United Kingdom

J. Fox

Guy's and St Thomas Hospital NHS Foundation Trust, London, United Kingdom

K. Seaton

Duke University, Durham, USA

G. Tomaras

Duke University, Durham, USA

M. Caskey

Rockefeller University, New York, USA

M. Nussenzweig

Rockefeller University, New York, USA

J. Frater

University of Oxford, Oxford, United Kingdom

S. Fidle

Imperial College London, London, United Kingdom